Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning, China.
Department of Thoracic Surgery, the First Hospital of China Medical University, Shenyang, Liaoning, China.
Cell Signal. 2023 Dec;112:110892. doi: 10.1016/j.cellsig.2023.110892. Epub 2023 Sep 18.
Breast cancer (BC) is a major threat to women's health. BC is a heterogeneous disease and treatment strategies and outcomes differ between subtypes. Investigating the molecular mechanisms of BC will help to identify potential therapeutic targets and develop new therapies. Here we report that zinc finger protein 746 (ZNF746), a Krüppel-associated box and zinc finger protein, exhibits tumour-promoting properties in BC. Functional experiments (cell growth, colony formation, cell cycle analysis, and transwell analysis) were used to evaluate the proliferation, migration, and invasion capacity of BC cells. Immunohistochemistry was performed to detect the expression of ZNF746, CD163 (M2 macrophage marker), and HES1 (Notch target) in BC tissues. ZNF746 was highly expressed in BC tissues compared to adjacent paired non-tumour tissues. Patients with M1 BC had higher expression of ZNF746 compared to patients with non-metastatic (M0) BC, and higher expression of ZNF746 was associated with poorer overall survival. The immunohistochemical results showed a positive correlation between the expression of ZNF746 and the expression of CD163 or HES1. ZNF746 promoted BC cell proliferation, migration, and invasion and increased the expression of molecules essential for monocyte recruitment and differentiation (CCL2 and CSF1). Furthermore, THP-1 monocytes cultured in the conditioned medium derived from BC cells overexpressing ZNF746 exhibited enhanced M2 polarisation. In contrast, ZNF746 knockdown reduced BC cell proliferation, migration, and invasion and suppressed M2 polarisation. Mechanistically, ZNF746 promoted the activation of the Jagged1/Notch pathway, and the Jagged1 siRNA-mediated blockade of this pathway prevented the tumour-promoting functions of ZNF746. In conclusion, this study uncovers the role of ZNF746 in promoting M2 macrophage polarisation and suggests that ZNF746 may be a promising therapeutic target for limiting BC progression.
乳腺癌(BC)是女性健康的主要威胁。BC 是一种异质性疾病,不同亚型的治疗策略和结果存在差异。研究 BC 的分子机制将有助于确定潜在的治疗靶点并开发新的治疗方法。在这里,我们报告锌指蛋白 746(ZNF746),一种 Krüppel 相关盒和锌指蛋白,在 BC 中表现出促进肿瘤的特性。功能实验(细胞生长、集落形成、细胞周期分析和 Transwell 分析)用于评估 BC 细胞的增殖、迁移和侵袭能力。免疫组织化学用于检测 BC 组织中 ZNF746、CD163(M2 巨噬细胞标志物)和 HES1(Notch 靶标)的表达。与相邻配对非肿瘤组织相比,BC 组织中 ZNF746 表达较高。与非转移性(M0)BC 患者相比,M1 BC 患者的 ZNF746 表达更高,并且 ZNF746 的高表达与总体生存较差相关。免疫组织化学结果显示 ZNF746 的表达与 CD163 或 HES1 的表达呈正相关。ZNF746 促进 BC 细胞增殖、迁移和侵袭,并增加单核细胞募集和分化(CCL2 和 CSF1)所必需的分子的表达。此外,在过表达 ZNF746 的 BC 细胞条件培养基中培养的 THP-1 单核细胞表现出增强的 M2 极化。相比之下,ZNF746 敲低降低了 BC 细胞的增殖、迁移和侵袭,并抑制了 M2 极化。在机制上,ZNF746 促进 Jagged1/Notch 通路的激活,并且 Jagged1 siRNA 介导的阻断该通路可防止 ZNF746 的促肿瘤功能。总之,这项研究揭示了 ZNF746 在促进 M2 巨噬细胞极化中的作用,并表明 ZNF746 可能是限制 BC 进展的有前途的治疗靶点。